MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Is past use of statins associated with lower incidence of Parkinson’s disease?

    TTH. Nguyen, A. Fournier, F. Artaud, E. Courtois, S. Escolano, P. Tubert-Bitter, MC. Boutron, G. Severi, E. Roze, I. Degaey, M. Canonico, I. Ahmed, A. Thiébaut, A. Elbaz (Villejuif, France)

    Objective: To examine the relation of past exposure to statins with Parkinson’s disease (PD) incidence. Background: Drug repurposing has recently emerged as a promising approach…
  • MDS Virtual Congress 2021

    Depression in Patients with Parkinson’s disease among Tomsk population

    M. Nikitina, N. Alifirova, K. Nurzhanova, N. Zhukova (Tomsk, Russian Federation)

    Objective: To identify clinical predictors of depression in Tomsk PwPD. Background: Depression is often an under-recognized feature of Parkinson's disease (PD). It is important to…
  • MDS Virtual Congress 2021

    Mortality of people with Parkinson’s disease in a large population-based cohort study. Time trends and relationship to disease progression.

    O. Okunoye, L. Horsfall, L. Marston, K. Walters, A. Schrag (London, United Kingdom)

    Objective: To explore how PD mortality rates have changed over time and their relationship to disease progression, age, gender and social deprivation using a large…
  • MDS Virtual Congress 2021

    The COVID-19 Pandemic Impact on Advanced Parkinson’s Disease in the US

    D. Oleske, S. Talapala, P. Kukreja, M. Facheris, R. Dorsey, S. Dey, A. Isherwood (North Chicago, USA)

    Objective: Characterize the risk of seven acute medical events in persons with advanced Parkinson’s disease (PD) using real world data before and within 12 months…
  • MDS Virtual Congress 2021

    Reproductive factors and risk of Parkinson’s disease in women: preliminary results from the French prospective cohort E3N.

    G. Pesce, F. Artaud, E. Roze, I. Degaey, A. Fournier, MC. Boutron-Ruault, A. Elbaz, M. Canonico (Villejuif, France)

    Objective: Objective: To evaluate whether reproductive factors and use of exogenous hormones are associated with the risk of Parkinson’s disease (PD) in women. Background: Background:…
  • MDS Virtual Congress 2021

    Body mass index and incidence of Parkinson’s disease in French women from the E3N cohort study

    B. Portugal, F. Artaud, C. Domenighetti, E. Roze, I. Dagaey, M. Canonico, A. Elbaz (Villejuif, France)

    Objective: We examined the association between BMI and PD incidence in women from the E3N cohort with repeated BMI measures over 29 years of follow-up,…
  • MDS Virtual Congress 2021

    The prevalence and types of postural deformities in Thai patients with Parkinson’s disease: A single-center study

    M. Vichutavate, P. Srivanitchapoom (Bangkok, Thailand)

    Objective: To address overall prevalence of Postural deformities(PostD) and each type of PostD (AC, TC, UC, and PS) in PD and healthy volunteers (HVs) Background:…
  • MDS Virtual Congress 2021

    Epidemiology of Huntington Disease in Tatarstan republic, Russia. One-moment investigation

    Z. Zalyalova, S. Munasipova, D. Khasanova (Kazan, Russian Federation)

    Objective: This study aims to estimate the prevalence of HD and analyze structure of patients in Tatarstan republic based on data of Republican Consultative and…
  • MDS Virtual Congress 2021

    Neuropsychiatric evaluation in patients with functionel movements disorders

    M. Balal, S. çakmak, M. Demirkiran (Adana, Turkey)

    Objective: The aim of this study is to investigate the neuropsychiatric evaluations in patients with functional movement disorders. Background: Functional movement disorders include a group…
  • MDS Virtual Congress 2021

    Virtual Rehabilitation for Functional Movement Disorder

    H. Bhatt, L. Macgillivray, K. Marcelle, S. Lidstone (Toronto, Canada)

    Objective: We describe initial experiences using virtual rehabilitation in a specialized outpatient functional movement disorder (FMD) clinic. Background: Specialized rehabilitation programs have been shown to…
  • « Previous Page
  • 1
  • …
  • 714
  • 715
  • 716
  • 717
  • 718
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley